Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gay M Crooks

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Blood Advances|June 20, 2020
Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopeniaMarita Bosticardo, Francesca Pala, Enrica Calzoni, et al.
Cell Reports. Medicine|November 29, 2021
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapyYan-Ruide Li, Yang Zhou, Yu Jeong Kim, et al.
Science Translational Medicine|February 7, 2024
Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiencyMaria Carmina Castiello, Chiara Brandas, Samuele Ferrari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2018
IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent Cancer-Targeted Immune SystemCristina Puig-Saus, Giulia Parisi, Angel Garcia-Diaz, et al.
Blood|September 13, 2012
Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plansFabio Candotti, Kit L Shaw, Linda Muul, et al.
Cell Stem Cell|September 10, 2019
Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for CancerYanni Zhu, Drake J Smith, Yang Zhou, et al.
The New England Journal of Medicine|May 11, 2021
Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase DeficiencyDonald B Kohn, Claire Booth, Kit L Shaw, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Blood Advances|June 20, 2020
Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopeniaMarita Bosticardo, Francesca Pala, Enrica Calzoni, et al.
Cell Reports. Medicine|November 29, 2021
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapyYan-Ruide Li, Yang Zhou, Yu Jeong Kim, et al.
Science Translational Medicine|February 7, 2024
Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiencyMaria Carmina Castiello, Chiara Brandas, Samuele Ferrari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2018
IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent Cancer-Targeted Immune SystemCristina Puig-Saus, Giulia Parisi, Angel Garcia-Diaz, et al.
Blood|September 13, 2012
Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plansFabio Candotti, Kit L Shaw, Linda Muul, et al.
Cell Stem Cell|September 10, 2019
Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for CancerYanni Zhu, Drake J Smith, Yang Zhou, et al.
The New England Journal of Medicine|May 11, 2021
Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase DeficiencyDonald B Kohn, Claire Booth, Kit L Shaw, et al.
Pageof 10